A novel approach to medical radioisotope production using inverse kinematics: A successful production test of the theranostic radionuclide Cu.

A novel method for the production of important medical radioisotopes has been developed. The approach is based on performing the nuclear reaction in inverse kinematics, namely sending a heavy-ion beam of appropriate energy on a light target (e.g.

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.

Background And Aim: The treatment of hepatitis C (HCV) with interferon (IFN)-free direct-acting antivirals (DAAs) is anticipated to change the future burden of disease. The aim of this study is to quantify the impact of IFN-free DAAs on HCV-related morbidity and mortality in Greece under different scenarios concerning treatment coverage and primary prevention, including the proposed by World Health Organization Global Hepatitis Strategy.

Methods: A previously described model was used to project the future disease burden up to 2030 under scenarios, which includes treatment based on the combination of pegylated-IFN with ribavirin (base case) and scenarios using DAAs therapies.

Enhanced production of neutron-rich rare isotopes in peripheral collisions at Fermi energies.

A large enhancement in the production of neutron-rich projectile residues is observed in the reactions of a 25 MeV/nucleon 86Kr beam with the neutron-rich 124Sn and 64Ni targets relative to the predictions of the EPAX parametrization of high-energy fragmentation, as well as relative to the reaction with the less neutron-rich 112Sn target. A hybrid model based on a deep-inelastic transfer (DIT) code followed by a statistical deexcitation code accounts for part of the observed large cross sections. The DIT simulation indicates that the production of neutron-rich nuclides in these reactions is associated with peripheral nucleon exchange in which the neutron skins of the neutron-rich 124Sn and 64Ni target nuclei may play an important role.